PAVmed Inc. Files Proxy Statement Addendum

Ticker: PAVM · Form: DEFA14A · Filed: May 9, 2025 · CIK: 1624326

Sentiment: neutral

Topics: proxy-statement, sec-filing, corporate-governance

TL;DR

PAVmed filed proxy docs, shareholders vote soon.

AI Summary

PAVmed Inc. filed a Definitive Additional Materials filing (DEFA14A) on May 9, 2025. This filing relates to the company's proxy statement and is subject to Section 14(a) of the Securities Exchange Act of 1934. The company, formerly known as PAXmed Inc., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This filing provides additional materials related to PAVmed Inc.'s proxy statement, which is crucial for shareholders to understand company proposals and exercise their voting rights.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement addendum and does not contain new financial information or significant corporate actions that would immediately impact risk.

Key Players & Entities

FAQ

What type of filing is PAVmed Inc. submitting?

PAVmed Inc. is submitting a Definitive Additional Materials filing (DEFA14A).

When was this filing made?

The filing was made on May 9, 2025.

What is the company's former name?

The company's former name was PAXmed Inc.

In which state is PAVmed Inc. incorporated?

PAVmed Inc. is incorporated in Delaware (DE).

What is the company's primary industry classification?

The company's Standard Industrial Classification is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 9, 2025 regarding PAVmed Inc. (PAVM).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing